Cullinan Oncology Competitors and Similar CompaniesClear all
Cullinan Oncology's competitors and similar companies include ImmunoMet, Moleculin Biotech, Corvus Pharmaceuticals and Immunome.
 Cullinan Oncology Cullinan Oncology is a company that develops cancer treatments and a portfolio of oncology therapeutics. |  ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. |  Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. | |
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2006 | Founding Date 2014 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Houston, US HQ | Locations Houston, US HQ | Locations Burlingame, US HQ | Locations Exton, US HQ |
Employees | Employees 11131% increase | Employees 814% increase | Employees 176% decrease | Employees 4911% decrease | Employees 264% decrease |
Valuation ($) | Valuation ($) 981 m | Valuation ($) N/A | Valuation ($) 7.5 m | Valuation ($) 556.1 m | Valuation ($) 746.5 m |
Financial | |||||
Net income | Net income ($219.9m) (FY, 2025) | Net income N/A | Net income ($33.6m) (FY, 2025) | Net income ($15.3m) (FY, 2025) | Net income ($212.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 248.5m | Total funding raised N/A | Total funding raised $ 491k | Total funding raised N/A | Total funding raised $ 23.8m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoMet
HQ
Houston, US
Employees
8↑ 14% increase
ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism.
View companyMoleculin Biotech
HQ
Houston, US
Employees
17↓ 6% decrease
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View companyCorvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
View companyImmunome
HQ
Exton, US
Employees
26↓ 4% decrease
Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system.
View company